= .920).ConclusionsBased on the available evidence, P Flap appears to offer more durable speech outcomes than FZP for the primary treatment of SMCP, with significantly lower reoperation rates. However, the potential for increased OSA risk following P Flap highlights the importance of patient-specific surgical planning that balances velopharyngeal function with airway safety.
Mokhtar et al. (Thu,) studied this question.